Glenmark Pharmaceuticals is Hiring Clinical Research Associate
Navi MumbaiB.Pharm / M.Pharm / B.Sc / M.Sc
Glenmark Pharmaceuticals is hiring for multiple positions into the Clinical Monitoring role based at Mahape, Navi Mumbai.
Role : Clinical Research Associate
Experience: 3 years in on-site Clinical Monitoring
Location: Mahape, Navi Mumbai
Interested candidates can reach out at the mentioned email address Akanksha.Chilka@Glenmarkpharma.com with the subject line as: Clinical Monitoring
Please Note: Due to high number of applications only the relevant profiles will be reached out to discuss the role.
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited is a globally present, research-driven pharmaceutical company operating across branded, generic, and over-the-counter (OTC) segments, with a strategic focus on Respiratory, Dermatology, and Oncology therapies. The company operates four R&D centers and ten advanced manufacturing facilities across five continents, serving more than 80 countries worldwide.
As part of its ambition to become one of the first Indian pharmaceutical firms to introduce an innovative drug globally, Glenmark is following a dual approach: one centered on discovering novel chemical and biological entities, and the other on advancing the value chain by developing specialty treatments—such as RYALTRIS®—that fulfill unmet medical needs.
In collaboration with its U.S.-based wholly-owned subsidiary Ichnos Sciences, Glenmark has established ‘Ichnos Glenmark Innovation’—a partnership combining diverse modalities, cutting-edge technologies, and shared expertise to tackle cancer. This alliance boasts a strong pipeline of novel molecules in various phases of clinical development, targeting oncology and immunology.
Guided by the vision of “A New Way for a New World,” Glenmark remains committed to leveraging its strengths in innovation, scientific research, and deep medical knowledge to challenge conventional treatments and deliver impactful solutions that enhance patient care across global markets.